Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Vitamin D Receptor is needed for hair growth in mice but not for skin stem cell maintenance.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.